Index/Topics/Ivermectin Toxicity

Ivermectin Toxicity

The toxic effects of ivermectin when used inappropriately, including hospitalization and death.

Fact-Checks

13 results
Jan 12, 2026
Most Viewed

What are the documented adverse effects in humans at ivermectin doses ≥1 mg/kg or with parenteral administration?

Published human data document a consistent pattern of toxic effects when ivermectin is used at high oral doses or misused (including veterinary formulations), dominated by central‑nervous‑system depre...

Jan 16, 2026
Most Viewed

What are the differences in toxicity between veterinary and human formulations of ivermectin?

The clinical literature and poison‑center reporting show a consistent pattern: veterinary ivermectin exposures more often involve large, untested doses and formulations (pastes, solutions) that produc...

Jan 16, 2026
Most Viewed

How does ivermectin toxicity from veterinary formulations differ clinically from toxicity at high human therapeutic doses?

Reports from poison centers and clinical series show two distinct clinical pictures: acute neurotoxicity after ingestion of veterinary ivermectin products taken in large doses or over short periods, v...

Jan 20, 2026

What safety concerns and dose-limiting toxicities are associated with higher ivermectin doses?

High or “off‑label” ivermectin dosing raises two linked safety questions: are higher exposures intrinsically toxic, and do specific contexts (co‑infections, genetics, formulations, drug interactions) ...

Jan 18, 2026

Are there patient risk factors that make ivermectin toxicity more likely than a typical allergic response?

Yes—there are identifiable patient and situational risk factors that raise the likelihood of ivermectin toxicity (pharmacologic overdose or CNS/organ toxicity) beyond an immediate allergic reaction; p...

Jan 17, 2026

What official FDA statements and case reports exist about human poisonings from veterinary ivermectin?

The U.S. Food and Drug Administration (FDA) repeatedly warned that ivermectin is not authorized or approved to prevent or treat COVID‑19 in humans and alerted the public that people taking veterinary ...

Jan 17, 2026

What clinical features and outcomes distinguish toxicity from veterinary-formulated ivermectin versus human-dose ivermectin in published case series?

Published case series and poison‑center reviews show a clear pattern: toxicity linked to veterinary ivermectin is driven by higher ingested doses and unusual routes/formulations and presents with more...

Jan 17, 2026

What are the common side effects of ivermectin overdose?

Ivermectin overdose commonly produces gastrointestinal symptoms (nausea, vomiting, diarrhea), dizziness and other central nervous system effects (drowsiness, headache, tremor), and in more severe case...

Jan 13, 2026

What are the clinical risks and documented adverse events from human ingestion of animal ivermectin or phenylbutazone products?

Animal formulations of ivermectin have been repeatedly linked to gastrointestinal symptoms, rapid-onset neurotoxicity (including confusion, loss of coordination, seizures, coma) and at least one repor...

Jan 11, 2026

How do ivermectin side effects differ with dose and formulation (oral vs topical)?

Oral ivermectin produces systemic adverse effects that are dose-related and occasionally severe when taken inappropriately or at very high doses, whereas topical formulations confine most effects to l...

Jan 8, 2026

What health risks and side effects occur from humans taking horse ivermectin products?

Horse ivermectin products are veterinary formulations of the antiparasitic drug ivermectin intended for large animals and are not approved or tested for human use . Using these products for COVID-19 o...

Jan 7, 2026

How soon after exposure do ivermectin toxicity symptoms appear compared with allergic reactions?

Ivermectin adverse effects follow multiple timelines: toxic neurologic or gastrointestinal effects from large or inappropriate doses can appear within hours, while parasite-related reactions and many ...

Jan 7, 2026

Which regulatory and ethical concerns do oncologists cite about repurposing antiparasitic drugs like ivermectin for cancer treatment?

Oncologists cite a cluster of regulatory and ethical concerns about repurposing antiparasitics like ivermectin for cancer: there is a stark gap between promising lab data and human evidence, known tox...